LNSRLENSAR, Inc.

$142M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$14M+10.3% YoY

Gross Profit

$7M50.4% margin

Operating Income

-$6M-45.1% margin

Net Income

-$2M-12.7% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-1.6%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$766,000

Balance Sheet

Total Assets

$70M

Total Liabilities

$80M

Stockholders' Equity

-$9M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$13M	+10.3%
Gross Profit	$7M	$7M	+6.7%
Operating Income	-$6M	-$2M	-305.5%
Net Income	-$2M	-$9M	+80.5%

Revenue Segments

Product

$11M89%

Service

$1M11%

Geographic Segments

UNITED STATES

$8M63%

Europe

$2M20%

Asia Excluding South Korea

$2M15%

KOREA, REPUBLIC OF

$181,0001%

Other Geographical Region

$76,0001%

LNSR Q2 2025 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena